Zosano Pharma Corp. (ZSAN) Stock on a Precipitous Decline, Here’s Why
Zosano Pharma Corp. (ZSAN), a clinical-stage company related to the biopharmaceutical industry, has plunged 28.67% in aftermarket trading session. As a result, it is trading at $0.154 at the time of the writing. During Friday’s mid-day session, the stock declined by 3.49% and closed the $0.215. The stock went into the plunge after the company’s […]
